Researchers at UMC Utrecht have discovered that converting monoclonal antibodies from the IgG to the IgM isotype can significantly broaden their ability to recognize and bind multiple human-relevant ...

The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus that causes severe acute respiratory distress in a significant proportion of ...

A team of scientists from Texas Biomedical Research Institute have homed in on an antibody that could protect against infection with HIV-1. As reported in the journal AIDS, Dr Ruth Ruprecht and ...

IGM Biosciences is developing antibodies that are different from most monoclonal antibodies currently in use. They have two main pipeline projects focused on cancer and rheumatologic disease. The ...

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal ...

The frequency and the diagnostic value of IgG and IgM antibodies to capsid antigen of Epstein-Barr virus (EBV) were studied in 40 children in whom the diagnosis of infectious mononucleosis was ...

Sanofi will pay IGM Biosciences $150 million and potentially billions more in milestone payments as part of a deal to develop agonist antibodies for cancer and inflammatory diseases. The well-known ...

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies ...

MOUNTAIN VIEW, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (IGM), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today ...

Ab to the capsular antigen of Hib is considered protective in humans, but the role of Ab of various immunoglobulin classes and subclasses is not well known. We evaluated the protective nature of sera ...

SAN DIEGO--(BUSINESS WIRE)--AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager ...